10 March 2014 - Deborah Wilkes
Archived
Safety concerns have prompted the Pharmacovigilance Risk Assessment Committee (PRAC) to recommend restrictions on the use of medicines containing domperidone throughout the European Union.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.